LADENBURG THALMANN FINANCIAL SERVICES INC. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 47 filers reported holding NEOS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,0000.0%5200.0%0.00%
Q3 2019$1,0000.0%5200.0%0.00%
Q2 2019$1,0000.0%5200.0%0.00%
Q1 2019$1,0000.0%5200.0%0.00%
Q4 2018$1,000
-66.7%
5200.0%0.00%
Q3 2018$3,000
-25.0%
520
-7.5%
0.00%
Q2 2018$4,0000.0%5620.0%0.00%
Q1 2018$4,000
-20.0%
562
+8.1%
0.00%
Q4 2017$5,000
-50.0%
520
-66.2%
0.00%
Q3 2016$10,000
-28.6%
1,5370.0%0.00%
Q2 2016$14,000
-17.6%
1,5370.0%0.00%
Q1 2016$17,0001,5370.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders